Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2009 Mar 16;91(Suppl 161):77–88. doi: 10.1111/j.1600-0404.1995.tb05861.x

Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies

K Lauer 1,✉
PMCID: PMC7159802  PMID: 7653250

The content is available as a PDF (1.2 MB).

References

  1. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol 1991: 133: 635–648. [DOI] [PubMed] [Google Scholar]
  2. Rothman K. Modern epidemiology. Boston: Little, Brown, 1986. [Google Scholar]
  3. Ruse T., et al. Guidelines for analytical epidemiological studies of multiple sclerosis (in preparation).
  4. Greenland S., Robins J. Invited commentary: ecological studies — biases, misconceptions, and counterexamples. Am J Epidemiol 1994: 139: 747–760. [DOI] [PubMed] [Google Scholar]
  5. Swank R., Lerstad O., Ström A., Backer J. Multiple sclerosis in rural Norway. Its geographic and occupational incidence in relation to nutrition. New Engl J Med 1952: 246: 721–728. [DOI] [PubMed] [Google Scholar]
  6. Zec N. La sclerosi a placche in Bosnia ed Erzegovina. Minerva Med 1959: 50: 1224–1233. [PubMed] [Google Scholar]
  7. Hamdi TI. Multiple sclerosis in Iraq: a clinical and geomedical survey. J Postgrad Med 1974: 21: 1–9. [PubMed] [Google Scholar]
  8. Cernacek J., Varsik P., Uiházyiová D., Traubner P. The relation of geographical and meteorological factors to the occurrence of multiple sclerosis in Czechoslovakia. Acta Neurol Scand 1971: 47: 227–232. [DOI] [PubMed] [Google Scholar]
  9. Amprino D., Lisante F., Barnaba A., Dellarosa A., Megna G. Ricerca epidemiologica sulla sclerosi multiple nella Provincia di Bari. Acta Neurol (Napoli) 1977: 32: 818–832. [PubMed] [Google Scholar]
  10. Baertschi‐Rochaix W. Multiple Sklerose im Wallis. Bern: H. Huber, 1977. [Google Scholar]
  11. Norman JE, Kurtzke JF, Beebe GW. Epidemiology of multiple sclerosis in U.S. veterans. 2. Latitude, climate, and the risk of multiple sclerosis. J Chron Dis 1983: 36: 551–559. [DOI] [PubMed] [Google Scholar]
  12. Petrescu A., Verdes F. Epidemiology of multiple sclerosis in Romania. Rev Roum Méd Neurol Psychiatrie 1989: 27: 261–271. [PubMed] [Google Scholar]
  13. Levic Z., Pavicevic M., Pantovic M., et al. Epidemiology of multiple sclerosis in Montenegro. Symposium 'Actual aspects of multiple sclerosis', Igalo, Yugoslavia, May 1989.
  14. Lauer K. A factor‐analytical study of the multiple‐sclerosis mortality in Hesse and Baden‐Wuerttemberg, Germany. J Publ Health (Weinheim) 1993: 1: 319–327. [Google Scholar]
  15. Jedlicka P., Benes B., Hron B., et al. Epidemiology of MS in the Czech Republic. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 261–265. [Google Scholar]
  16. Ljapchev R., Daskalovska V. Epidemiological studies of multiple sclerosis in the Republic of Macedonia. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 301–308. [Google Scholar]
  17. Lauer K. Epidemiologische Charakteristika der multiplen Sklerose in Südhessen. Inform Biometrie Epidemiol Med Biol (Stuttgart) 1994: 25: 84–92. [Google Scholar]
  18. Mutlu The effect of geographical and meteorological factors on the incidence of multiple sclerosis in Turkey. Acta Neurol Scand 1960: 35 (Suppl. 147): 47–54. [DOI] [PubMed] [Google Scholar]
  19. Beebe GW, Kurtzke JF, Kurland LT, Auth TL, Nagler B. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II. Neurology 1967: 17: 1–17. [DOI] [PubMed] [Google Scholar]
  20. Morariu M., Alter M., Harshe M. Multiple sclerosis in Transylvania. A zone of transition in frequency. Neurology 1974: 24: 673–679. [DOI] [PubMed] [Google Scholar]
  21. Pantovic M., Levic Z. Epidemiological study of multiple sclerosis in the area of Kragujevac and a review of other epidemiological research of MS in Yugoslavia. In: Pedersen E., Clausen J., Oades L., eds. Actual problems in multiple sclerosis research. Copenhagen: FADL, 1983: 224–226. [Google Scholar]
  22. Lauer K. Multiple sclerosis in relation to geographic factors in France. Neuroepidemiology 1990: 9: 113–117. [DOI] [PubMed] [Google Scholar]
  23. Antón‐Aranda E., Martinez‐Lage JM, Maravi Petri E., Gallego Cullere J., de Castro P. Epidemiologia y aspectos clinicoevolutivos de la esclerosis multiple en Navarra. Neurologia 1991: 6: 160–169. [PubMed] [Google Scholar]
  24. Middleton LT, Dean G. Multiple sclerosis in Cyprus. J Neurol Sci 1991: 103: 29–36. [DOI] [PubMed] [Google Scholar]
  25. Lauer K., Firnhaber W. Die Multiple‐Sklerose‐Mortalität 1973–1987 in Baden‐Württemberg im Vergleich mit soziogeographischen Variablen. Nervenarzt 1992: 63: 209–212. [PubMed] [Google Scholar]
  26. Barlow J. Correlation of the geographic distribution of multiple sclerosis with cosmic ray intensities. Acta Neurol Scand 1960: 35 (Suppl.147): 108–130. [DOI] [PubMed] [Google Scholar]
  27. Resch J. Relation in space and time between the frequency of multiple sclerosis and geophysical factors. In: Firnhaber W., Lauer K. (eds) Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 159–165. [Google Scholar]
  28. Kreienbrock L., Poffijn A., Tirmarche M., Kayser P., Darby S., Wichmann HE. Radon and lung cancer in the Ardennes and Eifel region — Concepts and experiences of an international epidemiological study. Med Inform Biometr Epidemiol (Munich) 1993: 76: 19–23. [Google Scholar]
  29. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Neurol Scand 1960: 35 (Suppl. 147): 132–147. [DOI] [PubMed] [Google Scholar]
  30. Kalafatova OI. Geographic and climatic factors and multiple sclerosis in some districts of Bulgaria. Neuroepidemiology 1987: 6: 116–119. [DOI] [PubMed] [Google Scholar]
  31. Tjazhkorob AM, Masjuk WA, Yarosh AA. Rasprostranenje rassejanogo skleroza w USSR. Vrachebnoe Delo (Kiev) 1987: 9: 115–117. [PubMed] [Google Scholar]
  32. Yarosh AA, Molnar L., Skochiy PG, et al. Rasprostranennostje rassejanogo skleroza w Karpatskom regione. Vrachebnoe Delo (Kiev) 1988: 4: 89–91. [PubMed] [Google Scholar]
  33. Lauer K. The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor‐analytical study. J Clin Epidemiol 1994: 47: 43–48. [DOI] [PubMed] [Google Scholar]
  34. Lauer K. Multiple sclerosis in the Old World: the new old map. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 14–27. [Google Scholar]
  35. Alpérovitch A., Bouvier MH. Geographical pattern of death rates from multiple sclerosis in France. An analysis of 4012 deaths. Acta Neurol Scand 1982: 66: 454–461. [DOI] [PubMed] [Google Scholar]
  36. Dauphiné A., Ottavi JY. Atlas structurel des climats de la France. Montpellier: GIP Reclus, 1986. [Google Scholar]
  37. Miller DH, Hammond SR, McLoed JG, Purdie G., Skegg DCG Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatr 1990: 53: 903–905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gentilli J. Climates of Australia and New Zealand. Amsterdam: Elsevier, 1971. [Google Scholar]
  39. Republika e Shqiperise. Ministria e ekonomise. Drejtoria e statistikes. Vjetari statistikor i Sqiperise — Statistical yearbook of Albania. Tirana: own edition, 1991. [Google Scholar]
  40. Afoke AO, Eeg‐Olofsson O., Hed J., Kjellman NIM, Lindblom B., Ludvigsson J. Seasonal variation and sex differences of circulating macrophages, immunoglobulins and lymphocytes in healthy school children. Scand J Immunol 1993: 37: 209–215. [DOI] [PubMed] [Google Scholar]
  41. Graham NMH. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev 1990: 12: 149–178. [DOI] [PubMed] [Google Scholar]
  42. Gwaltney JM. Virology and immunology of the common cold. Rhinology 1985: 23: 265–271. [PubMed] [Google Scholar]
  43. Tupasi TE, de Leon LE, Lupisan S., et al. Community‐based studies of acute respiratory tract infections in young children. Rev Inf Dis 1990: 12 (suppl. 8) 940–949. [Google Scholar]
  44. Murray RS, Brown B., Brian D., Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 1992: 31: 525–533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stewart JN, Mounir S., Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 1992: 191: 502–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Alvord EC. Disseminated encephalomyelitis: its variations in form and their relationships to other diseases of the nervous system. In: Vinken PJ, Bruyn GW, Koetsier JC, eds. Handbook of clinical neurology, Vol. 3(47): demyelinating diseases. Amsterdam: Elsevier, 1985: 467–502. [Google Scholar]
  47. Lauer K. A possible paradox in the immunology of multiple sclerosis: its apparent lack of 'specificity' might provide clues to the etiology. Med Hypotheses 1993: 40: 368–374. [DOI] [PubMed] [Google Scholar]
  48. Layton W. Aust M., Sutherland JM. Geochemistry and multiple sclerosis: a hypothesis. Med J Austr 1975: 1: 73–77. [DOI] [PubMed] [Google Scholar]
  49. Warren HV, Delavault RE, Cross CH. Possible correlations between geology and some disease patterns. Ann NY Acad Sci 1967: 136: 659–710. [Google Scholar]
  50. Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourgh, Saskatchewan, cluster focus. I. The water. Sci Tot Env 1989: 84: 45–59. [DOI] [PubMed] [Google Scholar]
  51. Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourgh, Saskatchewan, cluster focus. II. The soil. Sci Tot Env 1988: 77: 175–188. [DOI] [PubMed] [Google Scholar]
  52. Lauer K., Firnhaber W. Descriptive and analytical epidemiological data on multiple sclerosis from a long‐term study in Southern Hesse, Germany. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 147–158. [Google Scholar]
  53. Schou A., Antonsen K. Dänemark. In: Sömme A red. Die nordischen Lander. Braunschweig: Westermann, 1974: 97–140. [Google Scholar]
  54. Hyllested K. Disseminated sclerosis in Denmark. Copenhagen: Rosenkilde & Bakker, 1956. [Google Scholar]
  55. Potemkowski A., Walczak A., Nocon D., Fabian A., Nowacki P. Epidemiological analysis of multiple sclerosis in the Szczecin region, north‐western part of Poland (1960–1992). In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 249–254. [Google Scholar]
  56. Millar JHD. Multiple sclerosis in two high‐risk areas in Northern Ireland. J Ir Med Ass 1966: 59: 138–143. [PubMed] [Google Scholar]
  57. Boiko A. Multiple sclerosis prevalence in Russia and other countries of the former USSR. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 219–230. [Google Scholar]
  58. Dwyer DJ. The peat bogs in the Irish Republic: A problem in land use. Geograph J 1962: 128: 184–193. [Google Scholar]
  59. Brady R., Secerbegovic S., Dean G., Secerbegovic AM. Multiple sclerosis in the Republic of Ireland. J Ir Med Ass 1977: 70: 500–506. [PubMed] [Google Scholar]
  60. Lauer K. Sociogeographic factors and multiple sclerosis. An ecological study in 6 European countries. Neuroepidemiology 1988: 7: 122–129. [DOI] [PubMed] [Google Scholar]
  61. Petrescu A. Epidemiology of multiple sclerosis in Rumania. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 287–293. [Google Scholar]
  62. Materljan E., Sepcic J. Multiple sclerosis in Croatia. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiolgical update. Alsbach/Bergstrasse: LTV Press, 1994: 295–300. [Google Scholar]
  63. Koncan‐Vracko B. Epidemiological investigations of multiple sclerosis in Slovenia. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 294. [Google Scholar]
  64. Heske F. World forestry atlas. Hamburg: P. Parey, 1973. [Google Scholar]
  65. Goettlich K. Moor‐ und Torfkunde. Stuttgart: E. Schweizerbart, 1980. [Google Scholar]
  66. Sarkanen KV, Ludwig CH. Lignins. Occurrence, formation, structure and reactions. New York: Wiley, 1971. [Google Scholar]
  67. Pálffy G. MS in Hungary. In: Battaglia MA, Crimi G., eds. An update on multiple sclerosis. Bologna: Monduzzi, 1989: 293–297. [Google Scholar]
  68. Lauer K. Risk of multiple sclerosis in relation to industrial activities: an ecological study in four European countries. Neuroepidemiology 1989: 8: 38–42. [DOI] [PubMed] [Google Scholar]
  69. Crönert H., Dalpke HL, Kilpper W., Pothmann D., Berndt W. Papier, Faserrohstoffe. In: Bartholomé E., Biekert E., Hellmann H., Ley H., Weigert WM, Weise E., eds. Ullmanns Enzyklopädie der technischen Chemie, 4th edition, vol 1. Weinheim‐New York: Verlag Chemie, 1979: 531–576. [Google Scholar]
  70. Lowis GW. The social epidemiology of disease with particular emphasis on multiple sclerosis. Sci Tot Env 1992: 126: 139–164. [DOI] [PubMed] [Google Scholar]
  71. Lauer K., Firnhaber W. Epidemiologische Aspekte der multiplen Sklerose. Versicherungsmedizin 1992: 44: 125–130. [PubMed] [Google Scholar]
  72. Amaducci L., Arfaioli C., Inzitari D., Marchi M. Multiple sclerosis among the shoe and leather workers: an epidemiological survey in Florence. Acta Neurol Scand 1982: 65: 94–103. [DOI] [PubMed] [Google Scholar]
  73. Guiliani G., Brizioli E., Angeleri VA, Caraffa G., Faschi N., Speranzini C. The organic glue solvents in the pathogenesis of multiple sclerosis: an epidemiological study. In: Battaglia MA, Crimi G., eds. An update on multiple sclerosis. Bologna: Monduzzi, 1989: 243–247. [Google Scholar]
  74. Landtblom AM, Flodin U., Karlsson M., Paalhagen S., Axelson O., Söderfeldt B. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Env Health 1993: 19: 399–404. [DOI] [PubMed] [Google Scholar]
  75. Grønning M., Albrektsen G., Kvåle G., Moen B., Aarli JA, Nyland H. Organic solvents and multiple sclerosis: a case‐control study. Acta Neurol Scand 1993: 88: 247–250. [DOI] [PubMed] [Google Scholar]
  76. Shepherd DI, Downie AW. Prevalence of multiple sclerosis in north‐east Scotland. Br Med J 1978: 2: 314–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Shepherd DI. Increased risk of multiple sclerosis among nurses and doctors. J Neurol Neurosurg Psychiatry 1991: 54: 848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Dean G., Gray R. DO nurses or doctors have an increased risk of developing multiple sclerosis? J Neurol Neurosurg Psychiatr 1990: 53: 899–902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Lauer K. The pattern of occupations during adolescence in MS patients: Results from an epidemiological area. Conference on multiple sclerosis of the South‐East European Society of Neurology and Psychiatry, Poznan, Poland, June 1991.
  80. Kelsey JL, Githens PB, Walter SD, et al. An epidemiological study of acute prolapsed cervical intervertebral disc. J Bone Joint Surg 1984: 66 A: 907–914. [DOI] [PubMed] [Google Scholar]
  81. Poser CM. Trauma and multiple sclerosis. J Neurol 1987: 254: 155–159. [DOI] [PubMed] [Google Scholar]
  82. Swingler RJ, Compston DAS. Demographic characteristics of multiple sclerosis in South‐East Wales. Neuroepidemiology 1990: 9: 68–77. [DOI] [PubMed] [Google Scholar]
  83. Poskanzer DC, Schapira K., Miller H. Multiple sclerosis and poliomyelitis. Lancet 1963: 2: 917–921. [DOI] [PubMed] [Google Scholar]
  84. Antonovsky A., Leibowitz U., Smith HA, et al. Reappraisal of possible etiologic factors in multiple sclerosis. Am J Publ Hyg 1968: 58: 836–848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Cendrowski W., Wender M., Dominik W., Flejsierowicz Z., Owsianowski M., Popiel M. Epidemiological study of multiple sclerosis in Western Poland. Eur Neurol 1969: 2: 90–108. [DOI] [PubMed] [Google Scholar]
  86. Poskanzer DC, Sheridan JL, Prenney LB, Walker AM. Multiple sclerosis in the Orkney and Shetland Islands. II. The search for an exogenous etiology. J Epidemiol Comm Health 1980: 34: 240–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Westlund KB, Kurland LT. Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana. II. A controlled investigation of factors in the life history of the Winnipeg patients. Am J Hyg 1953: 57: 397–407. [DOI] [PubMed] [Google Scholar]
  88. Hiller JE, McMichael AJ. Ecological studies. In: Margetts BM, Nelson N., eds. Design concepts in nutritional epidemiology. Oxford: Oxford University Press, 1991: 323–353. [Google Scholar]
  89. Weinshenker BG, Nelson R. Symposium summary: the second Canadian conference on multiple sclerosis. Can J Neurol Sci 1990: 17: 53–60. [DOI] [PubMed] [Google Scholar]
  90. Holzach M. Das vergessene Volk. Ein Jahr bei den deutschen Hutterern in Kanada. Hamburg: Hoffmann & Campe, 1980. [Google Scholar]
  91. Kurtzke JF. Epidemiology of multiple sclerosis. In: Ko‐etsier JC, ed. Handbook of clinical neurology, vol. 3(47). Amsterdam: Elsevier, 1985: 259–287. [Google Scholar]
  92. Kruja J. Multiple sclerosis in Albania. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 309–315. [Google Scholar]
  93. Diercke C., Dehmel R. Diercke Weltatlas. Braunschweig: G. Westermann, 1957. [Google Scholar]
  94. Schwalm H., Matl J., Spuler B., Müller L. Kirchen und Glaubensgemeinschaften in Jugoslawien. In: Markert W., ed. Osteuropahandbuch: Jugoslawien. Cologne: Böhlau‐Verlag, 1954: 14–36. [Google Scholar]
  95. Alter M., Yamoor M., Harshe M. Multiple sclerosis and nutrition. Arch Neurol 1974: 31: 267–272. [DOI] [PubMed] [Google Scholar]
  96. Knox EG. Foods and diseases. Br J Prev Soc Med 1977: 31: 71–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Agranoff BWA, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet 1974: 2: 1061–1066. [DOI] [PubMed] [Google Scholar]
  98. Murrell TGC, Matthews BJ. Multiple sclerosis: one manifestation of neurobrucellosis? Med Hypotheses 1990: 33: 43–48. [DOI] [PubMed] [Google Scholar]
  99. Sepcic J., Mesaros E., Materljan E., Sepcic‐Grahovac D. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology 1993: 12: 234–240. [DOI] [PubMed] [Google Scholar]
  100. Granieri E., Tola MR. Experience in multiple sclerosis epidemiology in Italy. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 195–207. [Google Scholar]
  101. Wender M., Kazmierski R. The descriptive and analytical epidemiology of multiple sclerosis in Western Poland. In: Firnhaber W., Lauer K., eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994: 241–248. [Google Scholar]
  102. Ben Shlomo Y., Smith GD, Marmot MG. Dietary fat in the epidemiology of multiple sclerosis: has the situation been adequately assessed? Neuroepidemiology 1992: 11: 214–225. [DOI] [PubMed] [Google Scholar]
  103. Malosse D., Perron H., Sasco A., Seigneurin JM. Correlation betwen milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology 1992: 11: 304–312. [DOI] [PubMed] [Google Scholar]
  104. Clausen J., Hoff‐Jörgensen N., Rasmussen HB. Antibody reactivity against animal retroviruses in multiple sclerosis. Acta Neurol Scand 1990: 81: 223–228. [DOI] [PubMed] [Google Scholar]
  105. Nanji AA, Narod S. Multiple sclerosis, latitude and dietary fat: is pork the missing link? Med Hypotheses 1986: 20: 279–282. [DOI] [PubMed] [Google Scholar]
  106. Warren SA, Warren KG, Greenhill S., Paterson M. How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Ass J 1982: 126: 377–385. [PMC free article] [PubMed] [Google Scholar]
  107. Berr C., Puel J., Clanet M., Ruydavet JB, Mas JL, Alpérovitch A. Risk‐factors in multiple sclerosis: a population‐based case‐control study in Hautes‐Pyrénées, France. Acta Neurol Scand 1989: 80: 46–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology 1986: 36: 307–328. [DOI] [PubMed] [Google Scholar]
  109. LAuer K. Dietary changes in temporal relation to multiple sclerosis in the Faroe Islands. An evaluation of literary sources. Neuroepidemiology 1989: 8: 200–206. [DOI] [PubMed] [Google Scholar]
  110. Lauer K. Multiple sclerosis in relation to meat preservation in France and Switzerland. Neuroepidemiology 1989: 8: 308–315. [DOI] [PubMed] [Google Scholar]
  111. Lauer K. The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near‐East region. J Epidemiol Comm Health 1991: 45: 251–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Wegner TH, Baker AJ, Bendtsen BA, et al. Wood. In: Mark HF, Othmer DF, Overberger CG, Seaborg GT, eds. Kirk‐Othmer encyclopedia of chemical technology. Vol. 24 New York: Wiley, 1984: 579–611. [Google Scholar]
  113. Joensen JP. Fiskafólk. Tórshavn: Føroya Sparikassi, 1982. [Google Scholar]
  114. Kurtzke JF, Hyllested K., Heltberg A., Olsen A. Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission. Acta Neurol Scand 1993: 88: 161–173. [PubMed] [Google Scholar]
  115. Knowles ME, Gilbert J., McWeeny DJ. Phenols in smoked, cured meats: nitrosation of phenols in liquid smokes and smoked bacon. J Sci Food Agr 1975: 26: 267–276. [DOI] [PubMed] [Google Scholar]
  116. Chen LB, Issenberg P. Interactions of some wood smoke components with epsilon‐aminogroups in proteins. J Agr Food Chem 1972: 20: 1113–115. [Google Scholar]
  117. Tóth L. Chemie der Räucherung. Weinheim: Verlag Chemie, 1983. [Google Scholar]
  118. Larsson BK, Pyysalo H., Sauri M. Class separation of mutagenic polycyclic organic material in grilled and smoked foods. Zschr Lebensm Unters Forsch 1988: 187: 546–551. [DOI] [PubMed] [Google Scholar]
  119. Berneman A., Guilbert B., Eschrich S., Avrameas S. IgG auto‐ and polyreactivities of normal human sera. Mol Immunol 1993: 30: 1499–1510. [DOI] [PubMed] [Google Scholar]
  120. Blancher A., Matsiota P., Guilbert B., et al. Autoantibodies in serum and CSF of patients with multiple sclerosis Ann NY Acad Sci 1988: 290–292. [DOI] [PubMed] [Google Scholar]
  121. Hafler DA, Matsui M., Wucherpfennig KW, Ota K., Weiner HL. The potential of restricted T cell recognition of myelin basic protein epitopes in the therapy of multiple sclerosis. Ann NY Acad Sci 1991: 636: 251–265. [DOI] [PubMed] [Google Scholar]
  122. Jingwu Z., Medaer R., Hashim GA, Chin Y., van den Berg‐Loonen E., Raus JCM. Myelin basic protein‐specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 1992: 32: 330–338. [DOI] [PubMed] [Google Scholar]
  123. Warren KG, Catz I. Synthetic peptide specificity of antimyelin basic protein from multiple sclerosis cerebrospinal fluid. J Neuroimmunol 1992: 39: 81–90. [DOI] [PubMed] [Google Scholar]
  124. Varga JM, Kalchschmid G., Klein GF, Fritsch P. Mechanism of allergic cross‐reactions. I. Multispecific binding of ligands to a mouse monoclonal anti‐DNP IgE antibody. Mol Immunol 1991: 28: 641–654. [DOI] [PubMed] [Google Scholar]
  125. Shatin R. Multiple sclerosis and geography. New interpretation of epidemiological observations. Neurology 1964: 14: 335–344. [DOI] [PubMed] [Google Scholar]
  126. Palo J., Wikström J., Kivalo E. Further studies on the epidemiology of multiple sclerosis in Finland. Acta Neurol Scand 1973: 49: 495–501. [DOI] [PubMed] [Google Scholar]
  127. Malosse D., Perron H. Correlation analysis between bovine poulations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology 1993: 12: 15–27. [DOI] [PubMed] [Google Scholar]
  128. Kurtzke JF, Priester WA. Dogs, distemper and multiple sclerosis in the United States. Acta Neurol Scand 1979: 60: 312–319. [DOI] [PubMed] [Google Scholar]
  129. Lauer K., Firnhaber W. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis. Acta Neurol Scand 1987: 76: 12–18. [DOI] [PubMed] [Google Scholar]

Articles from Acta Neurologica Scandinavica are provided here courtesy of Wiley

RESOURCES